Use of Prescription and Over-the-counter Medications and Dietary Supplements Among Older Adults in the United States
By D. Qato, G. Alexander, R. Conti, Michael Johnson, P. Schumm, Marnie L. Stacy, Tessler Lindau, Mapp R. Journal of the American Medical Association (JAMA), 2008
1,011 citations recorded by the source corpus.
Context Despite concerns about drug safety, current information on older adults’ use of prescription and over-the-counter medications and dietary supplements is limited. Objective To estimate the prevalence and patterns of medication use among older adults (including concurrent use), and potential major drug-drug interactions. Design, Setting, and Participants Three thousand five community-residing individuals, aged 57 through 85 years, were drawn from a cross-sectional, nationally representative probability sample of the United States. In-home interviews, including medication logs, were administered between June 2005 and March 2006. Medication use was defined as prescription, over-the-counter, and dietary supplements used “on a regular schedule, like every day or every week.” Concurrent use was defined as the regular use of at least 2 medications. Main Outcome Measure Population estimates of the prevalence of medication use, concurrent use, and potential major drug-drug interactions, stratified by age group and gender. Results The unweighted survey response rate was 74.8% (weighted response rate, 75.5%). Eighty-one percent (95% confidence interval [CI], 79.4%–83.5%) used at least 1 prescription medication, 42% (95% CI, 39.7%–44.8%) used at least 1 over-the-counter medication, and 49% (95% CI, 46.2%–52.7%) used a dietary supplement. Twenty-nine percent (95% CI, 26.6%–30.6%) used at least 5 prescription medications concurrently; this was highest among men (37.1%; 95% CI, 31.7%–42.4%) and women (36.0%; 95% CI, 30.2%–41.9%) aged 75 to 85 years. Among prescription medication users, concurrent use of over-the-counter medications was 46% (95% CI, 43.4%–49.1%) and concurrent use of dietary supplements was 52% (95% CI, 48.8%–55.5%). Overall, 4% of individuals were potentially at risk of having a major drug-drug interaction; half of these involved the use of nonprescription medications. These regimens were most prevalent among men in the oldest age group (10%; 95% CI, 6.4%–13.7%) and nearly half involved anticoagulants. No contraindicated concurrent drug use was identified. Conclusions In this sample of community-dwelling older adults, prescription and nonprescription medications were commonly used together, with nearly 1 in 25 individuals potentially at risk for a major drug-drug interaction.
Subfields: Complementary and alternative medicine, Family Practice, Geriatrics and Gerontology
View Paper: https://www.semanticscholar.org/paper/68d9817d38ee67d7a584c4b941e4b4e70842f0b8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Robert L. Maher
- A. Rowland
- J. Hanlon
- J. Miners
- Emily R Hajjar
- S. Heinrich
- S. Riedel-Heller
- H. König
Citations in the corpus
- Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis (2014, background): “Awareness Poor insight(46) 47 49 Misc PIMs (3); Older (2) and all ages (1); Primary (2) and secondary care (1) “When I saw the list of patients [to be discussed with the researcher], I was quite happy about the prescriptions.”
- Trends in Prescription Drug Use among Adults in the United States from 1999–2012 (2015, neutral): “5-13] 25-<30 1684 939 (57) [52-62] 245 (12) [10-15] 30-<35 1066 1066 (62) [58-66] 212 (17) [15-19] 35-<40 451 284 (68) [60-75] 109 (24) [18-30] ≥40 354 250 (73) [66-78] 117 (29) [24-35] a All paticipants were aged 20 years or older.”
- The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification. (2013, background): “It has been estimated that DDIs account for up to 4% of ospital admissions in western countries (Bjorkman et al., 2002; irmohamed et al., 2004; Qato et al., 2008), and this may increase nto the future as a result of an ageing population with multiple co- orbidities and the inevitable trend towards…”
- Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders (2014, neutral): “used over-the-counter and dietary supplements [1372].”
- Review: Health Care Utilization and Costs of Elderly Persons With Multiple Chronic Conditions (2011, background): “…use multiple medications (polypharmacy) are at increased risk for adverse drug events (Gandhi et al., 2003; Lin, Liao, Cheng, Wang, & Hsueh, 2008; Qato et al., 2008; Simonson & Feinberg, 2005; Zhang et al., 2009; Zhen et al., 2001), while adverse drug events pose a significant cost to health…”
- Clinical consequences of polypharmacy in elderly (2014, methodology): “Qato [5] Ambulatory/United States/ n = 2976 37.”